Literature DB >> 21346928

How should access to antiretroviral treatment be measured?

Leigh F Johnson1, Andrew Boulle.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21346928      PMCID： PMC3040380          DOI： 10.2471/BLT.10.080911

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  5 in total

1.  The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach.

Authors:  I M Longini; W S Clark; L I Gardner; J F Brundage
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

2.  Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men.

Authors:  J C Hendriks; G A Satten; I M Longini; H A van Druten; P T Schellekens; R A Coutinho; G J van Griensven
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

3.  Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.

Authors:  J C Hendriks; K J Craib; P J Veugelers; H A van Druten; R A Coutinho; M T Schechter; G J van Griensven
Journal:  Int J Epidemiol       Date:  2000-06       Impact factor: 7.196

4.  Estimation of adult antiretroviral treatment coverage in South Africa.

Authors:  Muhammad Aarif Adam; Leigh F Johnson
Journal:  S Afr Med J       Date:  2009-09

Review 5.  Estimation of antiretroviral therapy coverage: methodology and trends.

Authors:  Mary Mahy; Jean-Michel Tassie; Peter D Ghys; John Stover; Michel Beusenberg; Priscilla Akwara; Yves Souteyrand
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283
  5 in total
  9 in total

1.  HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.

Authors:  Amin Khademi; Denis Saure; Andrew Schaefer; Kimberly Nucifora; R Scott Braithwaite; Mark S Roberts
Journal:  Value Health       Date:  2015-11-12       Impact factor: 5.725

2.  Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.

Authors:  Manuel Koller; Kunjal Patel; Benjamin H Chi; Kara Wools-Kaloustian; Fatoumata Dicko; Kulkanya Chokephaibulkit; Cleophas Chimbetete; Dorita Avila; Rohan Hazra; Samual Ayaya; Valeriane Leroy; Huu Khanh Truong; Matthias Egger; Mary-Ann Davies
Journal:  J Acquir Immune Defic Syndr       Date:  2015-01-01       Impact factor: 3.731

3.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

4.  New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.

Authors:  Jacques D A Ndawinz; Xavier Anglaret; Eric Delaporte; Sinata Koulla-Shiro; Delphine Gabillard; Albert Minga; Dominique Costagliola; Virginie Supervie
Journal:  Bull World Health Organ       Date:  2015-06-01       Impact factor: 9.408

5.  In Women's Eyes: Key Barriers to Women's Access to HIV Treatment and a Rights-Based Approach to their Sustained Well-Being.

Authors:  Luisa Orza; Emily Bass; Emma Bell; E Tyler Crone; Nazneen Damji; Sophie Dilmitis; Liz Tremlett; Nasra Aidarus; Jacqui Stevenson; Souhaila Bensaid; Calorine Kenkem; Gracia Violeta Ross; Elena Kudravtseva; Alice Welbourn
Journal:  Health Hum Rights       Date:  2017-12

6.  Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa.

Authors:  Leigh F Johnson; Rob E Dorrington; Haroon Moolla
Journal:  South Afr J HIV Med       Date:  2017-07-27       Impact factor: 2.744

7.  Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008.

Authors:  Patrick Kazooba; Ivan Kasamba; Kathy Baisley; Billy N Mayanja; Dermot Maher
Journal:  Trop Med Int Health       Date:  2012-08       Impact factor: 2.622

8.  Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi.

Authors:  Peter MacPherson; Eleanor E MacPherson; Daniel Mwale; Stephen Bertel Squire; Simon D Makombe; Elizabeth L Corbett; David G Lalloo; Nicola Desmond
Journal:  J Int AIDS Soc       Date:  2012-12-31       Impact factor: 5.396

9.  Targeting 90-90-90--don't leave children and adolescents behind.

Authors:  Mary-Ann Davies; Jorge Pinto
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.